Biotest Aktiengesellschaft (ETR: BIO3)
Germany
· Delayed Price · Currency is EUR 27.60
+0.10 (0.36%)
Jan 17, 2025, 5:36 PM CET
ETR: BIO3 Revenue
Biotest Aktiengesellschaft had revenue of 150.70M EUR in the quarter ending September 30, 2024, a decrease of -33.02%. This brings the company's revenue in the last twelve months to 707.00M, up 7.84% year-over-year. In the year 2023, Biotest Aktiengesellschaft had annual revenue of 684.60M with 32.65% growth.
Revenue (ttm)
707.00M
Revenue Growth
+7.84%
P/S Ratio
1.55
Revenue / Employee
291.43K
Employees
2,426
Market Cap
1.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 684.60M | 168.50M | 32.65% |
| Dec 31, 2022 | 516.10M | 500.00K | 0.10% |
| Dec 31, 2021 | 515.60M | 31.40M | 6.48% |
| Dec 31, 2020 | 484.20M | 65.10M | 15.53% |
| Dec 31, 2019 | 419.10M | 18.80M | 4.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 20.96B |
| Siemens Healthineers AG | 22.36B |
| Bayer Aktiengesellschaft | 46.74B |
| Fresenius SE & Co. KGaA | 22.81B |
| Sartorius Aktiengesellschaft | 3.32B |
| Fresenius Medical Care AG | 19.24B |
| Carl Zeiss Meditec AG | 2.07B |
| SCHOTT Pharma AG & Co. KGaA | 957.09M |
Biotest Aktiengesellschaft News
- 11 days ago - Biotest's Big Step: FDA Review for Fibrinogen Biologics - Wallstreet:Online
- 11 days ago - EQS-News: Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) - Wallstreet:Online
- 2 months ago - EQS-News: Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations - Wallstreet:Online
- 2 months ago - Biotest Boosts Revenue by 4.5% to €523M in First 9 Months! - Wallstreet:Online
- 2 months ago - EQS-News: Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million - Wallstreet:Online
- 2 months ago - Biotest AG: Revenue & Cash Flow Forecast Cut, EBIT Guidance Steady - Wallstreet:Online
- 2 months ago - EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged - Wallstreet:Online
- 3 months ago - Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US - Benzinga